Oxford announces landmark partnership for its COVID-19 vaccine
On 30 April 2020, the University of Oxford announced a landmark partnership with AstraZeneca to develop, manufacture, and distribute its COVID-19 vaccine candidate at global scale. Built on research led by the Jenner Institute and Oxford Vaccine Group, the effort made the university a central actor in the international pandemic response. The partnership linked Oxford’s scientific research to industrial production and public-health deployment on an unprecedented scale.